应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CING CINGULATE INC.
休市中 09-04 16:00:00 EDT
5.10
-0.12
-2.30%
盘后
5.04
-0.06
-1.15%
19:30 EDT
最高
5.50
最低
5.02
成交量
10.70万
今开
5.21
昨收
5.22
日振幅
9.16%
总市值
7,416万
流通市值
7,197万
总股本
1,454万
成交额
54.62万
换手率
0.76%
流通股本
1,411万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Cingulate旗下Ctx-1301在III期关键终点上展现出相较安慰剂的统计学显著改善
美股速递 · 07-30
Cingulate旗下Ctx-1301在III期关键终点上展现出相较安慰剂的统计学显著改善
Cingulate宣布其ADHD三期临床试验结果发表于《儿童与青少年精神药理学杂志》
美股速递 · 07-30
Cingulate宣布其ADHD三期临床试验结果发表于《儿童与青少年精神药理学杂志》
Cingulate Inc提交招股说明书补充文件,拟分阶段发行并出售最高1亿美元普通股
美股速递 · 03-25
Cingulate Inc提交招股说明书补充文件,拟分阶段发行并出售最高1亿美元普通股
CINGULATE INC.提交文件:林肯公园资本基金拟发售及转售最多350万股
美股速递 · 03-20
CINGULATE INC.提交文件:林肯公园资本基金拟发售及转售最多350万股
Cingulate Inc.盘中异动 股价大跌5.18%报3.65美元
市场透视 · 2025-03-05
Cingulate Inc.盘中异动 股价大跌5.18%报3.65美元
Cingulate Inc.盘中异动 临近收盘大幅下跌5.07%
市场透视 · 2025-03-04
Cingulate Inc.盘中异动 临近收盘大幅下跌5.07%
Cingulate Inc.盘中异动 早盘大幅下挫5.21%报4.00美元
市场透视 · 2025-02-28
Cingulate Inc.盘中异动 早盘大幅下挫5.21%报4.00美元
Cingulate Inc.盘中异动 快速跳水5.26%
市场透视 · 2025-02-25
Cingulate Inc.盘中异动 快速跳水5.26%
Cingulate Inc.盘中异动 早盘股价大涨6.02%报4.58美元
市场透视 · 2025-02-19
Cingulate Inc.盘中异动 早盘股价大涨6.02%报4.58美元
Cingulate Inc.盘中异动 下午盘股价大涨5.50%
市场透视 · 2025-02-12
Cingulate Inc.盘中异动 下午盘股价大涨5.50%
Cingulate Inc.盘中异动 股价大跌5.14%
市场透视 · 2025-02-08
Cingulate Inc.盘中异动 股价大跌5.14%
Cingulate Inc.盘中异动 早盘急速拉升5.68%报5.00美元
市场透视 · 2025-02-07
Cingulate Inc.盘中异动 早盘急速拉升5.68%报5.00美元
Cingulate Inc.盘中异动 下午盘大幅上涨5.27%
市场透视 · 2025-02-01
Cingulate Inc.盘中异动 下午盘大幅上涨5.27%
Cingulate Inc.盘中异动 早盘股价大跌5.27%
市场透视 · 2025-01-30
Cingulate Inc.盘中异动 早盘股价大跌5.27%
Cingulate Inc.盘中异动 下午盘快速跳水5.00%
市场透视 · 2025-01-30
Cingulate Inc.盘中异动 下午盘快速跳水5.00%
Cingulate Inc.盘中异动 股价大跌5.71%报4.79美元
市场透视 · 2025-01-27
Cingulate Inc.盘中异动 股价大跌5.71%报4.79美元
Cingulate Inc.盘中异动 股价大涨5.19%
市场透视 · 2025-01-23
Cingulate Inc.盘中异动 股价大涨5.19%
Cingulate Inc.盘中异动 早盘股价大跌5.04%
市场透视 · 2025-01-21
Cingulate Inc.盘中异动 早盘股价大跌5.04%
Cingulate Inc.盘中异动 股价大涨5.08%报4.96美元
市场透视 · 2025-01-17
Cingulate Inc.盘中异动 股价大涨5.08%报4.96美元
Cingulate Inc.盘中异动 股价大涨5.41%报4.87美元
市场透视 · 2025-01-16
Cingulate Inc.盘中异动 股价大涨5.41%报4.87美元
暂无数据
公司概况
公司名称:
CINGULATE INC.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Cingulate Inc.于2012年12月14日在特拉华州成立。该公司是一家生物制药公司,利用其专有的精准定时释放药物递送平台,为注意缺陷多动障碍和焦虑症开发下一代产品。其主要候选药物CTx-1301和CTx-1302旨在作为每日一次的多动症兴奋剂药物,同时也在开发CTx-2103,一种每日一次的丁螺环酮制剂,用于治疗焦虑症。
发行价格:
--
{"stockData":{"symbol":"CING","market":"US","secType":"STK","nameCN":"CINGULATE INC.","latestPrice":5.1,"timestamp":1788552000000,"preClose":5.22,"halted":0,"volume":106977,"hourTrading":{"tag":"盘后","latestPrice":5.0416,"preClose":5.1,"latestTime":"19:30 EDT","volume":1476,"amount":7573.8864,"timestamp":1788564604211,"change":-0.0584,"changeRate":-0.011451,"amplitude":0.021255},"delay":0,"changeRate":-0.022988505747126457,"floatShares":14111800,"shares":14541800,"eps":-3.56,"marketStatus":"休市中","change":-0.12,"latestTime":"09-04 16:00:00 EDT","open":5.21,"high":5.4979,"low":5.02,"amount":546161.4027792,"amplitude":0.091552,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.56,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":1633579200000,"exchange":"NASDAQ","adjPreClose":5.22,"preHourTrading":{"tag":"盘前","latestPrice":5.19,"preClose":5.22,"latestTime":"09:29 EDT","volume":205,"amount":1069.76011,"timestamp":1788528599111,"change":-0.03,"changeRate":-0.005747,"amplitude":0.01341},"postHourTrading":{"tag":"盘后","latestPrice":5.0416,"preClose":5.1,"latestTime":"19:30 EDT","volume":1476,"amount":7573.8864,"timestamp":1788564604211,"change":-0.0584,"changeRate":-0.011451,"amplitude":0.021255},"volumeRatio":0.9759766878557028,"impliedVol":1.3916,"impliedVolPercentile":0.1789},"requestUrl":"/m/hq/s/CING/tweets","defaultTab":"tweets","newsList":[{"id":"1116783650","title":"Cingulate旗下Ctx-1301在III期关键终点上展现出相较安慰剂的统计学显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1116783650","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116783650?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:34","pubTimestamp":1785414888,"startTime":"0","endTime":"0","summary":"Cingulate Inc.今日宣布,其候选药物Ctx-1301在III期临床试验的主要终点上,取得了相较安慰剂具有统计学显著意义的改善。这一积极数据,为这款备受瞩目的实验性疗法注入了强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","CINGW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115798612","title":"Cingulate宣布其ADHD三期临床试验结果发表于《儿童与青少年精神药理学杂志》","url":"https://stock-news.laohu8.com/highlight/detail?id=1115798612","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115798612?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:31","pubTimestamp":1785414671,"startTime":"0","endTime":"0","summary":"Cingulate正式对外发布,其针对注意力缺陷多动障碍(ADHD)的三期临床试验结果,已成功在权威学术期刊《儿童与青少年精神药理学杂志》上刊载。这一里程碑式的进展,不仅标志着该公司的研发实力获得了学术界的认可,也为ADHD的治疗领域注入了新的希望。此次发表的论文,详细阐述了试验的完整数据与关键发现,为后续的临床实践与药物开发提供了宝贵的循证依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","CINGW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164062833","title":"Cingulate Inc提交招股说明书补充文件,拟分阶段发行并出售最高1亿美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1164062833","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164062833?lang=zh_cn&edition=full","pubTime":"2026-03-25 05:21","pubTimestamp":1774387304,"startTime":"0","endTime":"0","summary":"Cingulate Inc已向美国证券交易委员会提交招股说明书补充文件,计划通过市场发行方式,分阶段出售总额最高达1亿美元的普通股。此次股票发行将根据市场状况和公司资金需求灵活进行,所得资金拟用于推进其核心候选药物的临床试验及一般企业用途。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116356752","title":"CINGULATE INC.提交文件:林肯公园资本基金拟发售及转售最多350万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1116356752","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116356752?lang=zh_cn&edition=full","pubTime":"2026-03-20 18:05","pubTimestamp":1774001102,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会(SEC)最新披露的文件,生物制药公司CINGULATE INC.已提交相关申请,其机构投资者林肯公园资本基金(Lincoln Park Capital Fund)计划发售及转售最多350万股公司普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517910048","title":"Cingulate Inc.盘中异动 股价大跌5.18%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910048?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185087,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分,Cingulate Inc.股票出现异动,股价快速下跌5.18%。截至发稿,该股报3.65美元/股,成交量1.5788万股,换手率0.49%,振幅3.12%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为0.08%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223127abe9b08d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223127abe9b08d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516663996","title":"Cingulate Inc.盘中异动 临近收盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516663996?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:44","pubTimestamp":1741034655,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时44分,Cingulate Inc.股票出现异动,股价大幅下挫5.07%。截至发稿,该股报3.91美元/股,成交量8.2184万股,换手率2.56%,振幅5.58%。Cingulate Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044415abe69a5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044415abe69a5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514373812","title":"Cingulate Inc.盘中异动 早盘大幅下挫5.21%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514373812?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:51","pubTimestamp":1740754268,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时51分,Cingulate Inc.股票出现波动,股价急速下跌5.21%。截至发稿,该股报4.00美元/股,成交量3.0594万股,换手率0.95%,振幅2.49%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为0.22%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822510896341eb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822510896341eb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514168210","title":"Cingulate Inc.盘中异动 快速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514168210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514168210?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:33","pubTimestamp":1740497627,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时33分,Cingulate Inc.股票出现异动,股价快速跳水5.26%。截至发稿,该股报3.96美元/股,成交量5.2281万股,换手率1.63%,振幅5.26%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为0.76%。其相关个股中,Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为1075.69%、596.43%、562.36%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为64.05%、61.16%、60.87%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233347a25395f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233347a25395f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512055488","title":"Cingulate Inc.盘中异动 早盘股价大涨6.02%报4.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512055488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512055488?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:32","pubTimestamp":1739975546,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时32分,Cingulate Inc.股票出现波动,股价大幅上涨6.02%。截至发稿,该股报4.58美元/股,成交量1.2204万股,换手率0.38%,振幅3.20%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大,Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃,换手率分别为212.30%、203.38%、65.72%,振幅较大的相关个股有Osr Holdings, Inc.、Azitra Inc、Opthea Limited,振幅分别为33.76%、11.29%、11.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192232269628cd63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192232269628cd63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510353290","title":"Cingulate Inc.盘中异动 下午盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510353290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510353290?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:39","pubTimestamp":1739299162,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日02时39分,Cingulate Inc.股票出现异动,股价大幅上涨5.50%。截至发稿,该股报4.60美元/股,成交量3.4534万股,换手率1.08%,振幅4.79%。Cingulate Inc.股票所在的生物技术行业中,整体跌幅为1.71%。其相关个股中,Omega Therapeutics, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为3095.68%、1441.83%、484.36%,振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.,振幅分别为143.33%、72.23%、58.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023922a242301a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023922a242301a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509572452","title":"Cingulate Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509572452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509572452?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:34","pubTimestamp":1738949691,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日01时34分,Cingulate Inc.股票出现波动,股价大幅下挫5.14%。截至发稿,该股报4.43美元/股,成交量4.2647万股,换手率1.33%,振幅9.21%。Cingulate Inc.股票所在的生物技术行业中,整体跌幅为0.62%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208013451987dcd8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208013451987dcd8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509050232","title":"Cingulate Inc.盘中异动 早盘急速拉升5.68%报5.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509050232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509050232?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:23","pubTimestamp":1738858997,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时23分,Cingulate Inc.股票出现波动,股价急速拉升5.68%。截至发稿,该股报5.00美元/股,成交量6.4538万股,换手率2.01%,振幅7.82%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207002317961a2ac1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207002317961a2ac1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508995439","title":"Cingulate Inc.盘中异动 下午盘大幅上涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508995439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508995439?lang=zh_cn&edition=full","pubTime":"2025-02-01 02:07","pubTimestamp":1738346872,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日02时07分,Cingulate Inc.股票出现异动,股价急速上涨5.27%。截至发稿,该股报4.79美元/股,成交量9.6368万股,换手率3.00%,振幅6.81%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为1.60%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020102075296150483&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020102075296150483&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507621821","title":"Cingulate Inc.盘中异动 早盘股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507621821?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:35","pubTimestamp":1738247719,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时35分,Cingulate Inc.股票出现波动,股价大幅跳水5.27%。截至发稿,该股报4.49美元/股,成交量5.4995万股,换手率1.71%,振幅8.44%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022351996143e20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022351996143e20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507651052","title":"Cingulate Inc.盘中异动 下午盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507651052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507651052?lang=zh_cn&edition=full","pubTime":"2025-01-30 02:39","pubTimestamp":1738175969,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日02时39分,Cingulate Inc.股票出现波动,股价快速跳水5.00%。截至发稿,该股报4.75美元/股,成交量5.7526万股,换手率1.79%,振幅4.20%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为1.34%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130023929a233900c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130023929a233900c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506306257","title":"Cingulate Inc.盘中异动 股价大跌5.71%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506306257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506306257?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:21","pubTimestamp":1737991266,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时21分,Cingulate Inc.股票出现波动,股价急速下跌5.71%。截至发稿,该股报4.79美元/股,成交量1.0272万股,换手率0.32%,振幅4.53%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为1.10%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232106abba6a42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232106abba6a42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505577977","title":"Cingulate Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505577977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505577977?lang=zh_cn&edition=full","pubTime":"2025-01-23 02:00","pubTimestamp":1737568844,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日02时00分,Cingulate Inc.股票出现波动,股价快速拉升5.19%。截至发稿,该股报5.07美元/股,成交量4.2571万股,换手率1.33%,振幅7.47%。Cingulate Inc.股票所在的生物技术行业中,整体跌幅为0.15%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123020044960d210b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123020044960d210b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505272878","title":"Cingulate Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505272878?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:04","pubTimestamp":1737471880,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时04分,Cingulate Inc.股票出现异动,股价大幅下跌5.04%。截至发稿,该股报4.52美元/股,成交量3.2377万股,换手率1.01%,振幅5.25%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为1.09%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230440986e39b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230440986e39b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504943331","title":"Cingulate Inc.盘中异动 股价大涨5.08%报4.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504943331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504943331?lang=zh_cn&edition=full","pubTime":"2025-01-17 01:29","pubTimestamp":1737048592,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日01时29分,Cingulate Inc.股票出现异动,股价大幅上涨5.08%。截至发稿,该股报4.96美元/股,成交量8.769万股,换手率2.73%,振幅5.97%。Cingulate Inc.股票所在的生物技术行业中,整体跌幅为0.23%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117012952a22487e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117012952a22487e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503627214","title":"Cingulate Inc.盘中异动 股价大涨5.41%报4.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503627214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503627214?lang=zh_cn&edition=full","pubTime":"2025-01-16 01:16","pubTimestamp":1736961412,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日01时16分,Cingulate Inc.股票出现波动,股价大幅拉升5.41%。截至发稿,该股报4.87美元/股,成交量4.0495万股,换手率1.26%,振幅4.98%。Cingulate Inc.股票所在的生物技术行业中,整体涨幅为0.92%。Cingulate Inc.公司简介:Cingulate Inc 是一家临床阶段的生物制药公司,利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道,旨在改善患有频繁诊断疾病的患者的生活,这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116011652986761da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116011652986761da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cingulate.com","stockEarnings":[{"period":"1week","weight":-0.0423},{"period":"1month","weight":0.0324},{"period":"3month","weight":0.1346},{"period":"6month","weight":-0.2068},{"period":"1year","weight":0.3456},{"period":"ytd","weight":0.1751}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cingulate Inc.于2012年12月14日在特拉华州成立。该公司是一家生物制药公司,利用其专有的精准定时释放药物递送平台,为注意缺陷多动障碍和焦虑症开发下一代产品。其主要候选药物CTx-1301和CTx-1302旨在作为每日一次的多动症兴奋剂药物,同时也在开发CTx-2103,一种每日一次的丁螺环酮制剂,用于治疗焦虑症。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.143656},{"month":2,"riseRate":0.4,"avgChangeRate":0.01358},{"month":3,"riseRate":0.4,"avgChangeRate":-0.044027},{"month":4,"riseRate":0.2,"avgChangeRate":-0.087813},{"month":5,"riseRate":0,"avgChangeRate":-0.196272},{"month":6,"riseRate":0.8,"avgChangeRate":0.034217},{"month":7,"riseRate":0.4,"avgChangeRate":-0.069094},{"month":8,"riseRate":0.8,"avgChangeRate":0.257116},{"month":9,"riseRate":0.2,"avgChangeRate":-0.127925},{"month":10,"riseRate":0.25,"avgChangeRate":-0.153936},{"month":11,"riseRate":0.25,"avgChangeRate":-0.072096},{"month":12,"riseRate":1,"avgChangeRate":0.130431}],"exchange":"NASDAQ","name":"CINGULATE INC.","nameEN":"CINGULATE INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CINGULATE INC.(CING)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CINGULATE INC.(CING)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CINGULATE INC.,CING,CINGULATE INC.股票,CINGULATE INC.股票老虎,CINGULATE INC.股票老虎国际,CINGULATE INC.行情,CINGULATE INC.股票行情,CINGULATE INC.股价,CINGULATE INC.股市,CINGULATE INC.股票价格,CINGULATE INC.股票交易,CINGULATE INC.股票购买,CINGULATE INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CINGULATE INC.(CING)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CINGULATE INC.(CING)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}